Active Not Recruiting OBSERVATIONAL NCT07338305
Methotrexat to Hand Eczema in the BIOSKIN Cohort (BIOSKIN: MTX)
The Copenhagen Translational Skin Immunology Biobank and Research Program - BIOSKIN: Methotrexat to Hand Eczema
Sponsor: Herlev and Gentofte Hospital
Conditions
Atopic Dermatitis Contact Dermatitis Hand Eczema
Updated 1 time since 2026 Last updated: Jan 5, 2026 Started: Nov 1, 2025 Primary completion: Sep 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07338305, this observational or N/A phase trial focuses on Atopic Dermatitis and Contact Dermatitis and remains ongoing. Sponsored by Herlev and Gentofte Hospital, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Herlev and Gentofte Hospital
- Lone Skov
- University of Copenhagen
Data source: Copenhagen University Hospital at Herlev
For direct contact, visit the study record on ClinicalTrials.gov .